Educational programming is being finalized for the 2015 Global Conference on Clinical Pharmacy, October 17–21, San Francisco, California. The Program Committee has put together a series of cutting-edge educational programs presented by some of the world’s leading practitioners and researchers. Sessions will feature interactive debates, panel discussions, and hands-on workshops intended to provide meeting attendees with the latest information and developments on clinical pharmacy’s leading topics.
One of the conference highlights will be the Keynote Address presented by Dr. Michael S. Barr, Executive Vice President, Research, Performance Measurement, and Analysis National Committee for Quality Assurance, in Washington, D.C. Dr. Barr’s presentation is titled “Measuring Quality in Patient-Centered Care—Challenges and Opportunities.” In addition, he will review the “big-picture framework” for quality measurement in the evolving U.S. health care delivery system and its alignment with international efforts and measures in other advanced countries. He will discuss “what quality means” to patients, providers, payers, and policy-makers and lessons learned to date from the various quality measurement approaches that have been developed and deployed in various payer markets. Dr. Barr will also identify areas of quality measurement in the area of medication use that clinical pharmacists can directly affect, and that align with and support, broader health quality goals and efforts.
Because this is a global conference, portions of the programming will be focused on providing an international perspective on emerging issues and challenges faced by today’s clinical practitioners. International and U.S.-based speakers will lead discussions centered on topics such as “Medication Safety: National and International Perspectives”; “Global Development of Clinical Pharmacy Education and Advancement of Clinical Pharmacy Practice”; and “Issues in International Research.”
Therapeutic topic areas affecting the global community will also be highlighted. These include “Updates in the Management of Viral Infections”; “Optimal Management of Community- and Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Infections”; and “Diabetes—A Global Pandemic.” The Global Conference will also feature a series of Late Breaker topic sessions in a variety of therapeutic areas: Cardiology, Critical Care, Pediatrics, Endocrinology and Metabolism, Pharmacogenomics, Transplantation, Women’s Health, Psychiatry, Vaccines/Immunizations, Geriatrics, Nephrology, and Neurology.
Sessions on pharmacy education will address topics on the latest innovations and the best practices/dilemmas in this area. In addition, sessions on “Innovations in Practice Technology” and “Advancing Clinical Pharmacy Practice: Innovative Models” will be featured.
This year’s Global Conference will offer a unique variety of educational programming sessions with exciting speakers and topics that will appeal to clinical pharmacy practitioners, educators, and researchers from around the world. We hope you’ll be able to join us, and we look forward to seeing you in San Francisco this fall.